Enzon Pharmaceuticals Revenue

In the year 2024, Enzon Pharmaceuticals had annual revenue of $26.00K.

Revenue

26.00K

Revenue Growth

n/a

P/S Ratio

242.62

Revenue / Employee

26.00K

Employees

Market Cap

6.31M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	26.00K	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	26.00K	-675.00K	-96.29%
Dec 31, 2021	701.00K	649.00K	1,248.08%
Dec 31, 2020	52.00K	-155.00K	-74.88%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
SS Innovations International	20.65M
Endo Inc.	1.76B
Veradigm	588.02M
Northwest Biotherapeutics	1.38M
Elite Pharmaceuticals	70.00M
Glass House Brands	200.90M
BioStem Technologies	301.83M
American Oncology Network	1.76B

Revenue Rankings

Enzon Pharmaceuticals News

4 years ago - Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon's CFO, to Assume Position of CEO and Remain CFO - GlobeNewsWire
4 years ago - Enzon Pharmaceuticals Announces Results of Rights Offering - GlobeNewsWire
5 years ago - Enzon Pharmaceuticals Announces Key Dates for Rights Offering - GlobeNewsWire
5 years ago - Enzon Pharmaceuticals, Inc. Announces Postponement of 2020 Annual Meeting - GlobeNewsWire
5 years ago - Enzon Pharmaceuticals Anticipated Rights Offering to Existing Shareholders - GlobeNewsWire
5 years ago - Enzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its NOL Assets and Shareholder Value - GlobeNewsWire
5 years ago - Bullish On Enzon And Sesen From Different Perspectives - Seeking Alpha
6 years ago - Enzon Pharmaceuticals - Heads Equals Royalties, Tails Equals Cash - Seeking Alpha

More News